 |
|
atiprimod
An orally bioavailable small molecule belonging to the azaspirane class of cationic amphiphilic agents with anti-inflammatory, antineoplastic, and antiangiogenic properties. Atiprimod inhibits the phosphorylation of signal transducer and activator of transcription 3 (STAT3), blocking the signalling pathways of interleukin-6 and vascular endothelial growth factor (VEGF) and downregulating the anti-apoptotic proteins Bcl-2, Bcl-XL, and Mcl-1, thereby inhibiting cell proliferation, inducing cell cycle arrest, and inducing apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | azaspirane | | | | Code names: | | SK&F106615
SK&F106615 | | | | Chemical structure name: | | N,N-diethyl-8,8-dipropyl-2-azaspiro(4.5)decane-2-propanamine | | |
|
|
